Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Seek emergency medical evaluation the same day if you experience severe, persistent upper abdominal pain, especially if accompanied by vomiting, fever, or pain radiating to your back
At lower doses, patients often experience fewer gastrointestinal symptoms such as nausea or vomiting, which can occur when GLP-1s are escalated too quickly
As a result, researchers theorize that murine models in the Ipamorelin groups could have consumed more food, leading to the observed weight gain